Abstract | AIMS: METHODS AND RESULTS:
Ceramides and PCs were analysed using liquid chromatography-mass spectrometry (LC-MS) in three studies: WECAC (The Western Norway Coronary Angiography Cohort) (N = 3789), LIPID (Long-Term Intervention with Pravastatin in Ischaemic Disease) trial (N = 5991), and KAROLA (Langzeiterfolge der KARdiOLogischen Anschlussheilbehandlung) (N = 1023). A simple risk score, based on the ceramides and PCs showing the best prognostic features, was developed in the WECAC study and validated in the two other cohorts. This score was highly significant in predicting CVD mortality [multiadjusted hazard ratios (HRs; 95% confidence interval) per standard deviation were 1.44 (1.28-1.63) in WECAC, 1.47 (1.34-1.61) in the LIPID trial, and 1.69 (1.31-2.17) in KAROLA]. In addition, a combination of the risk score with high-sensitivity troponin T increased the HRs to 1.63 (1.44-1.85) and 2.04 (1.57-2.64) in WECAC and KAROLA cohorts, respectively. The C-statistics in WECAC for the risk score combined with sex and age was 0.76 for CVD death. The ceramide- phospholipid risk score showed comparable and synergistic predictive performance with previously published CVD risk models for secondary prevention. CONCLUSION:
|
Authors | Mika Hilvo, Peter J Meikle, Eva Ringdal Pedersen, Grethe S Tell, Indu Dhar, Hermann Brenner, Ben Schöttker, Mitja Lääperi, Dimple Kauhanen, Kaisa M Koistinen, Antti Jylhä, Kevin Huynh, Natalie A Mellett, Andrew M Tonkin, David R Sullivan, John Simes, Paul Nestel, Wolfgang Koenig, Dietrich Rothenbacher, Ottar Nygård, Reijo Laaksonen |
Journal | European heart journal
(Eur Heart J)
Vol. 41
Issue 3
Pg. 371-380
(01 14 2020)
ISSN: 1522-9645 [Electronic] England |
PMID | 31209498
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Validation Study)
|
Copyright | © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology. |
Chemical References |
- Biomarkers
- Ceramides
- Phospholipids
|
Topics |
- Aged
- Atherosclerosis
(blood, diagnosis)
- Biomarkers
(blood)
- Ceramides
(blood)
- Chromatography, Liquid
(methods)
- Coronary Angiography
- Coronary Artery Disease
(blood, diagnosis)
- Female
- Humans
- Male
- Mass Spectrometry
(methods)
- Middle Aged
- Phospholipids
(blood)
- Prognosis
- Risk Assessment
(methods)
- Risk Factors
|